Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

2.

Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.

Kaunitz AM.

J Reprod Med. 1996 May;41(5 Suppl):419-27. Review.

PMID:
8725705
3.

Depot-medroxyprogesterone acetate, other injectable contraceptives, and cervical neoplasia.

La Vecchia C.

Contraception. 1994 Mar;49(3):223-30. Review.

PMID:
8200216
4.

Depo Provera. Position paper on clinical use, effectiveness and side effects.

Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.

Br J Fam Plann. 1999 Jul;25(2):69-76. Review. Erratum in: Br J Fam Plann 2000 Jan;26(1):52-3.

PMID:
10454658
5.

Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes.

Westhoff C.

J Reprod Med. 1996 May;41(5 Suppl):401-6. Review.

PMID:
8725702
6.

Depot medroxyprogesterone acetate contraception in women with medical problems.

Frederiksen MC.

J Reprod Med. 1996 May;41(5 Suppl):414-8. Review.

PMID:
8725704
7.

Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.

Kaunitz AM.

Int J Fertil Womens Med. 1998 Mar-Apr;43(2):73-83. Review.

PMID:
9609206
8.

Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary.

Lumbiganon P.

Contraception. 1994 Mar;49(3):203-9. Review.

PMID:
8200214
9.

The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review.

Moodley M, Moodley J, Chetty R, Herrington CS.

Int J Gynecol Cancer. 2003 Mar-Apr;13(2):103-10. Review.

PMID:
12657108
10.

Depo provera in perspective.

McGoldrick IA.

P N G Med J. 1981 Dec;24(4):274-9. Review.

PMID:
6461984
11.

Depot-medroxyprogesterone acetate (DMPA) and cancer: memorandum from a WHO meeting.

[No authors listed]

Bull World Health Organ. 1986;64(3):375-82. Review.

12.
13.

Bone density recovery after depot medroxyprogesterone acetate injectable contraception use.

Kaunitz AM, Arias R, McClung M.

Contraception. 2008 Feb;77(2):67-76. doi: 10.1016/j.contraception.2007.10.005. Review.

PMID:
18226668
14.

Breast cancer and depot-medroxyprogesterone acetate: a review.

Chilvers C.

Contraception. 1994 Mar;49(3):211-22. Review.

PMID:
8200215
15.

Depot medroxyprogesterone acetate and breast cancer. A review of current knowledge.

Chilvers CE.

Drug Saf. 1996 Sep;15(3):212-8. Review.

PMID:
8879975
16.

Monthly combined injectable contraceptives and neoplasia.

Skegg DC.

Contraception. 1994 May;49(5):435-9. Review.

PMID:
8045130
17.

Carcinoma of the cervix and oral contraceptives: epidemiological studies.

Vessey M, Grice D.

Biomed Pharmacother. 1989;43(3):157-60. Review.

PMID:
2673422
18.

Depot-medroxyprogesterone acetate (DMPA) and cancer: memorandum from a WHO meeting.

[No authors listed]

Bull World Health Organ. 1993;71(6):669-76. Review.

19.

Risk assessment issues in breast cancer.

Skegg DC.

Mutat Res. 1995 Dec;333(1-2):51-8. Review.

PMID:
8538636

Supplemental Content

Support Center